Ehab Atallah

Ehab Atallah

UNVERIFIED PROFILE

Are you Ehab Atallah?   Register this Author

Register author
Ehab Atallah

Ehab Atallah

Publications by authors named "Ehab Atallah"

Are you Ehab Atallah?   Register this Author

58Publications

950Reads

35Profile Views

Implementation and evaluation of high-dose methotrexate administration guidelines.

J Oncol Pharm Pract 2019 Oct 25;25(7):1675-1681. Epub 2018 Oct 25.

Froedtert & The Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1078155218808866
Publisher Site
http://dx.doi.org/10.1177/1078155218808866DOI Listing
October 2019

Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.

Oncologist 2019 Sep 3;24(9):1253-1258. Epub 2019 Apr 3.

Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0831DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738285PMC
September 2019

Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy Cessation.

Clin Lymphoma Myeloma Leuk 2019 Aug 13;19(8):480-487. Epub 2019 May 13.

Division of Hematology/Oncology, Medical College of Wisconsin and Froedtert Hospital, Milwaukee, WI.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650193016
Publisher Site
http://dx.doi.org/10.1016/j.clml.2019.05.007DOI Listing
August 2019

Incidence and survival of T-cell acute lymphoblastic leukemia in the United States.

Leuk Lymphoma 2019 May 8;60(5):1171-1178. Epub 2018 Nov 8.

a Division of Hematology/Oncology , Medical College of Wisconsin , Milwaukee , WI , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1522442DOI Listing
May 2019

Patients' perspectives on the definition of cure in chronic myeloid leukemia.

Leuk Res 2019 May 28;80:40-42. Epub 2019 Mar 28.

Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee 53226, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.03.007DOI Listing
May 2019

Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.

Acta Haematol 2018;139(3):171-175. Epub 2018 Mar 29.

Division of Hematology and Oncology and Department of Internal Medicine, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000487879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388419PMC
March 2019

Treatment-Free Remission in CML: the US Perspective.

Curr Hematol Malig Rep 2019 Feb;14(1):56-61

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-019-0496-8
Publisher Site
http://dx.doi.org/10.1007/s11899-019-0496-8DOI Listing
February 2019

Incorporating newer agents in the treatment of acute myeloid leukemia.

Leuk Res 2018 11 19;74:113-120. Epub 2018 Oct 19.

Divison of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126183044
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2018.10.008DOI Listing
November 2018

Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm.

Leuk Res 2018 10 24;73:21-23. Epub 2018 Aug 24.

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.08.014DOI Listing
October 2018

Incidence and survival of therapy related myeloid neoplasm in United States.

Leuk Res 2018 08 23;71:95-99. Epub 2018 Jul 23.

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee WI, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.07.013DOI Listing
August 2018

Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy.

Case Rep Hematol 2018 1;2018:6514604. Epub 2018 Aug 1.

Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/6514604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092972PMC
August 2018

Dasatinib dose management for the treatment of chronic myeloid leukemia.

Cancer 2018 04 25;124(8):1660-1672. Epub 2018 Jan 25.

Department of Hematology and Oncology, Versailles Medical Center, INSERM UMR 1173, University of Versailles Saint-Quenti-en-Yvelines, Paris Saclay, Le Chesnay, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31232
Publisher Site
http://dx.doi.org/10.1002/cncr.31232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901015PMC
April 2018

Will tyrosine kinase inhibitors be part of the treatment armamentarium for CML in the future?

Expert Opin Pharmacother 2018 02 7;19(2):79-81. Epub 2018 Jan 7.

b Leukemia program , Weill Medical College of Cornell University and The New York Presbyterian Hospital , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1421633DOI Listing
February 2018

Chronic Myeloid Leukemia: What Every Practitioner Needs to Know in 2017.

Am Soc Clin Oncol Educ Book 2017 ;37:468-479

From the Winship Cancer Institute, Emory University, Atlanta, GA; The University of Texas MD Anderson Cancer Center, Houston, TX; Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175712DOI Listing
December 2017

Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.

Curr Hematol Malig Rep 2017 10;12(5):415-423

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI, 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0404-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045428PMC
October 2017

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

J Clin Oncol 2017 Aug 9;35(24):2745-2753. Epub 2017 May 9.

Mikkael A. Sekeres and Aziz Nazha, Cleveland Clinic, Cleveland; Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Megan Othus and Anna Moseley, SWOG Statistical Center; Min Fang and Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan F. List, H. Lee Moffitt Cancer Center, Tampa, FL; Olatoyosi Odenike, University of Chicago, Chicago; Mario R. Velasco, Heartland NCORP/Cancer Care Specialists of Central Illinois, Decatur, IL; Richard M. Stone, Dana Farber Cancer Institute; Eyal C. Attar, Massachusetts General Hospital, Boston, MA; Steven D. Gore, Yale University, New Haven, CT; Mark R. Litzow, Mayo Clinic, Rochester, MN; Rena Buckstein, Sunnybrook Health Sciences Centre, Toronto; Elina K. Cook, Alyssa H. Cull, and Michael J. Rauh, Queen's University, Kingston, Ontario, Canada; Diane Roulston, University of Michigan, Ann Arbor, MI; Yanming Zhang, Memorial Sloan-Kettering Cancer Center, New York, NY; Rakesh Gaur, Kansas City National Cancer Institute Community Oncology Research Program, Prairie Village, KS; Ehab Atallah, Medical College of Wisconsin, Milwaukee, WI; and Harry P. Erba, University of Alabama, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.2510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562170PMC
August 2017

Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia.

Curr Hematol Malig Rep 2016 Apr;11(2):80-5

Department of Medicine, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs11899-016-03
Web Search
http://link.springer.com/10.1007/s11899-016-0306-5
Publisher Site
http://dx.doi.org/10.1007/s11899-016-0306-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860261PMC
April 2016

Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.

Clin Lymphoma Myeloma Leuk 2015 Jan 11;15(1):e1-5. Epub 2014 Jun 11.

Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361182PMC
January 2015

Myelodysplastic syndromes in the United States: an update for clinicians.

Ann Med 2014 Aug 10;46(5):283-9. Epub 2014 Apr 10.

The EMMES Corporation , Rockville, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07853890.2014.898863DOI Listing
August 2014

Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.

Int J Dermatol 2014 Jan 24;53(1):e13-4. Epub 2012 Sep 24.

Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA E-mail: of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-4632.2011.05350.xDOI Listing
January 2014

Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.

Clin Cancer Res 2014 Jan 31;20(2):490-8. Epub 2013 Oct 31.

Authors' Affiliations: The University of Chicago; Decatur Memorial Hospital, Decatur; Illinois Cancer Care, Peoria; Loyola University Medical Center, Maywood, Illinois; University of California, San Francisco, San Francisco; City of Hope, Duarte, California; University of Michigan Medical Center, Ann Arbor, Michigan; Medical College of Wisconsin, Milwaukee, Wisconsin; and National Cancer Institute, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310865PMC
January 2014

Clarifying the use of ruxolitinib in patients with myelofibrosis.

Oncology (Williston Park) 2013 Jul;27(7):706-14

Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
July 2013

Emerging drugs for myelofibrosis.

Expert Opin Emerg Drugs 2012 Dec;17(4):555-70

Medical College of Wisconsin Cancer Center, Neoplastic Diseases and Related Disorders, Department of Internal Medicine, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.2012.748748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009610PMC
December 2012

Chronic myelogenous leukemia for primary care physicians.

Dis Mon 2012 Apr;58(4):168-76

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.disamonth.2012.01.007DOI Listing
April 2012

Myeloproliferative neoplasms.

Dis Mon 2012 Apr;58(4):177-94

Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.disamonth.2012.01.002DOI Listing
April 2012

Nilotinib cardiac toxicity: should we still be concerned?

Authors:
Ehab Atallah

Leuk Res 2011 May 17;35(5):577-8. Epub 2011 Feb 17.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.01.021DOI Listing
May 2011

Recurrent deep vein thrombosis and pulmonary embolism in a young man with Klinefelter's syndrome and heterozygous mutation of MTHFR-677C>T and 1298A>C.

Blood Coagul Fibrinolysis 2010 Jun;21(4):372-5

Department of Medicine, Medical College of Wisconsin, Milwaukee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/mbc.0b013e32833894ebDOI Listing
June 2010

Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity.

Ann Pharmacother 2010 May 23;44(5):926-8. Epub 2010 Mar 23.

Division of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1M715DOI Listing
May 2010

Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy.

Leuk Lymphoma 2010 Mar 8;51(3):481-7. Epub 2010 Feb 8.

Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903552120DOI Listing
March 2010

Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors.

Leuk Res 2009 Aug 25;33(8):1144-6. Epub 2009 Apr 25.

Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521260900119
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2009.03.011DOI Listing
August 2009

Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms.

Expert Rev Anticancer Ther 2009 May;9(5):663-70

Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.09.14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176249PMC
May 2009

Practical considerations for the management of patients in the tyrosine kinase inhibitor era.

Semin Hematol 2009 Apr;46(2 Suppl 3):S16-21

Department of Haematology, University Hospital Galway, National University of Ireland, Galway, Ireland.

View Article

Download full-text PDF

Source
April 2009

Treatment strategies in myelodysplastic syndromes.

Cancer Invest 2008 Mar;26(2):208-16

Department of Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900701788122DOI Listing
March 2008

Congestive heart failure is a rare event in patients receiving imatinib therapy.

Blood 2007 Aug 20;110(4):1233-7. Epub 2007 Apr 20.

Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-070144DOI Listing
August 2007

Use of hypomethylating agents in myelodysplastic syndromes.

Clin Adv Hematol Oncol 2007 Jul;5(7):544-52

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
July 2007

Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase.

Curr Opin Hematol 2007 Mar;14(2):138-44

Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e32801684a3DOI Listing
March 2007

Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors.

Clin Lymphoma Myeloma 2007 Mar;7 Suppl 3:S105-12

Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
March 2007

The role of decitabine in the treatment of myelodysplastic syndromes.

Expert Opin Pharmacother 2007 Jan;8(1):65-73

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.8.1.65DOI Listing
January 2007

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med 2007 Jan;13(1):14; author reply 15-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0107-14DOI Listing
January 2007

Granulocyte transfusion.

Curr Opin Hematol 2006 Jan;13(1):45-9

Divison of Hematology/Oncology, Karmanos Cancer Institute, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
January 2006

Treatment of metastatic malignant melanoma.

Curr Treat Options Oncol 2005 May;6(3):185-93

Karmanos Cancer Institute, Wayne State University, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
May 2005